A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Benazepril (ATC N C09AA07) in the Treatment of Persistent Renal Dysfunction in Pre-eclamptic Women.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Benazepril (Primary)
- Indications Preeclampsia; Proteinuria
- Focus Therapeutic Use
- Acronyms RPPEC
Most Recent Events
- 01 May 2018 Biomarkers information updated
- 24 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 05 Apr 2010 New trial record